MSLN and neoplasm: For example, Lm vaccines against the tumor-associated antigens PAP (55) and mesothelin (56) had poor immunogenicity alone but were more effective as booster vaccines in the context of a heterologous prime-boost immunization regimen, similar to observations with GUCY2C (Figure 1) (57).